MarketWatch

Enable Injections Announces Agreement with Sobi(R) to Develop and Distribute Aspaveli(R) in Combination with enFuse(R) in Sobi Territories

The MarketWatch News Department was not involved in the creation of this content. Enable Injections Announces Agreement with Sobi(R) to Develop and Distribute Aspaveli(R) in Combination with enFuse(R) ...
Yahoo Finance

Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi

CINCINNATI, May 22, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable"), a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System (OBDS), today ...
MarketWatch

Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities

The MarketWatch News Department was not involved in the creation of this content. CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable") a healthcare innovation company ...
Business Insider

Enable Injections Commits to Cincinnati Growth with Increased Jobs

A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". The word "Markets Insider". Enable Injections reinforces commitment to ...
Nasdaq

Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution

Through this partnership, Aptar Digital Health will deliver a companion digital solution for Enable Injections’ enFuse® system designed to enhance the patient experience and support adherence-related ...
The Business Journals

Enable Injections lands first U.S. Food and Drug Administration approval

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Cincinnati’s top venture ...
Benzinga.com

Enable Injections Announces $215 Million Financing

CINCINNATI, Jan. 27, 2022 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a company developing and manufacturing the enFuse ® platform of investigational wearable drug delivery systems, is pleased ...
The Business Journals

Enable Injections shatters region's previous fundraising record with $215M Series C

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. It’s another round for the record books. Enable ...
abc27

Enable Injections Names Matthew Huddleston as Chief Commercial Officer

CINCINNATI, May 22, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® wearable drug delivery platform today ...
WCPO Cincinnati

Evendale company Enable Injections adds 250 jobs, seeks new headquarters

EVENDALE, Ohio — One of Greater Cincinnati’s fastest-growing startups is planning to consolidate three locations into one $45 million headquarters capable of holding more than 1,000 employees. Enable ...
MobiHealthNews

Enable Injections brings in $50M for wearable subcutaneous therapeutic delivery devices

Enable Injections, maker of manual and connected adhesive wearables for subcutaneously therapeutic delivery, has raised $50 million in a Series B round led by Sanofi, the company announced today. ORI ...